Broad and potent neutralizing activity of human IgG1 LALA antibody against SARS-CoV-2 variants

By | January 25, 2022
A new study has focused on the identification, in vitro binding, and potent neutralizing activity of STI-9167 (plutavimab) against live viruses and pseudotype viruses.